Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP578322.RAQIK-q4SYYEA__820gALVpETFseZK2ztA_K43r20H7KY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP578322.RAQIK-q4SYYEA__820gALVpETFseZK2ztA_K43r20H7KY130_assertion type Assertion NP578322.RAQIK-q4SYYEA__820gALVpETFseZK2ztA_K43r20H7KY130_head.
- NP578322.RAQIK-q4SYYEA__820gALVpETFseZK2ztA_K43r20H7KY130_assertion description "[We conclude that transamidation by TG2 transforms S100A11 into a covalently bonded homodimer that acquires the capacity to signal through the p38 MAPK pathway, accelerate chondrocyte hypertrophy and matrix catabolism, and thereby couple inflammation with chondrocyte activation to potentially promote OA progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP578322.RAQIK-q4SYYEA__820gALVpETFseZK2ztA_K43r20H7KY130_provenance.
- NP578322.RAQIK-q4SYYEA__820gALVpETFseZK2ztA_K43r20H7KY130_assertion evidence source_evidence_literature NP578322.RAQIK-q4SYYEA__820gALVpETFseZK2ztA_K43r20H7KY130_provenance.
- NP578322.RAQIK-q4SYYEA__820gALVpETFseZK2ztA_K43r20H7KY130_assertion SIO_000772 18523305 NP578322.RAQIK-q4SYYEA__820gALVpETFseZK2ztA_K43r20H7KY130_provenance.
- NP578322.RAQIK-q4SYYEA__820gALVpETFseZK2ztA_K43r20H7KY130_assertion wasDerivedFrom befree-20140225 NP578322.RAQIK-q4SYYEA__820gALVpETFseZK2ztA_K43r20H7KY130_provenance.
- NP578322.RAQIK-q4SYYEA__820gALVpETFseZK2ztA_K43r20H7KY130_assertion wasGeneratedBy ECO_0000203 NP578322.RAQIK-q4SYYEA__820gALVpETFseZK2ztA_K43r20H7KY130_provenance.